Role of apoptosis in pressure-overload cardiomyopathy

Journal of Cardiovascular Medicine

Volumn 9, Issue 3, 2008, Pages 227-232

  Anselmi, Amedeo ^a   Gaudino, Mario ^a   Baldi, Alfonso ^b   Vetrovec, George W ^c   Bussani, Rossana ^d   Possati, Gianfederico ^a   Abbate, Antonio ^c  

^a CATHOLIC UNIVERSITY   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^d UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Aortic stenosis; Apoptosis; Heart failure; Hypertension; Surgery

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; GLYCOPROTEIN GP 130; GUANINE NUCLEOTIDE BINDING PROTEIN; STAT PROTEIN; SURVIVIN;

AORTA STENOSIS; APOPTOSIS; CARDIOMYOPATHY; DETERIORATION; HEART FAILURE; HEART HYPERTROPHY; HEART VENTRICLE PRESSURE; HUMAN; NONHUMAN; OBSERVATIONAL STUDY; OXIDATIVE STRESS; PROGNOSIS; REVIEW;

ANIMALS; APOPTOSIS; CARDIOMYOPATHY, HYPERTROPHIC; DISEASE PROGRESSION; HUMANS; MYOCYTES, CARDIAC; STROKE VOLUME; VENTRICULAR PRESSURE;

EID: 40049084481     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e328277f1d7     Document Type: Review

References (49)

1. Carabello BA. Is it ever too late to operate on the patient with valvular heart disease? J Am Coll Cardiol 2004; 44:376-383.
2. Kaplan N. Systemic hypertension: mechanisms and diagnosis in heart disease, 6th edn. Philadelphia: WB Saunders; 2001.
3. Carabello BA. Clinical practice: aortic stenosis. New Engl J Med 2002; 346:677-682.
4. Otto CM. Valvular aortic stenosis - disease severity and timing of intervention. J Am Coll Cardiol 2006; 47:2141-2151.
5. Katz AM. Cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure. New Engl J Med 1990; 322:100-110.
6. Narula J, Haider N, Virmani R, DiSalvo TG, Kolodgie FD, Hajjar RJ, et al. Apoptosis in myocytes in end-stage heart failure. New Engl J Med 1996; 335:1182-1189.
7. Bussani R, Abbate A, Biondi-Zoccai G, Dobrina A, Leone AM, Camilot D, et al. Right ventricular dilatation after left ventricular acute myocardial infarction is predictive of extremely high peri-infarctual apoptosis at postmortem examination in humans. J Clin Pathol 2003;672-676.
8. Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, et al. Apoptosis in the failing human heart. N Engl J Med 1997; 336:1131-1141.
9. Curtis MJ. Characterization, utilization and clinical relevance of isolated perfused heart models of ischemia-induced ventricular fibrillation. Cardiovasc Res 1998; 39:194-215.
10. Cheng W, Li B, Kajstura J, Wolin MS, Sonnenblick EH, Hintze TH, et al. Stretch-induced programmed myocyte cell death. J Clin Invest 1995; 96:2247-2259.
11. Ross J Jr, Sonnenblick EH, Taylor RR, Spotnitz HM, Covell JW. Diastolic geometry and sorcomere lengths in the chronically dilated canine left ventricle. Circ Res 1971; 28:49-61.
12. Ding B, Price RL, Goldsmith EC, Borg TK, Yan X, Douglas PS, et al. Left ventricular hypertrophy in ascending aortic stenosis mice: anoikis and the progression to early failure. Circulation 2000; 101:2854-2862.
13. Mascareno E, Dhar Q, Siddiqui MA. Signal transduction and activator of transcription (STAT) protein-dependent activation of angiotensinogen promoter: a cellular signal for hypertrophy in cardiac muscle. Proc Natl Acad Sci 1998; 95:5590-5594.
14. Zhu YC, Zhu YZ, Lu N, Wang MJ, Wang YX, Yao T. Role of angiotensin AT1 and AT2 receptors in cardiac hypertrophy and cardiac remodelling. Clin Exp Pharmacol Physiol 2003; 30:911-918.
15. Chen MS, Xu FP, Wang YZ, Zhang GP, Yi Q, Zhang HQ, et al. Statins initiated after hypertrophy inhibit oxidative stress and prevent heart failure in rats with aortic stenosis. J Mol Cell Cardiol 2004; 37:889-896.
16. van Empel VP, Bertrand AT, van der Nagel R, van der Nagel R, Kostin S, Doevendans PA, et al. Downregulation of apoptosis-inducing factor in harlequin mutant mice sensitizes the myocardium to oxidative stress-related cell death and pressure overload-induced decompensation. Circ Res 2005; 96:e92-e101; Epub 2005 Jun 2.
17. Vogt M, Strauer BE. Systolic ventricular dysfunction and heart failure due to coronary microangiopathy in hypertensive heart disease. Am J Cardiol 1995; 76:48D-53D.
18. Hein S, Arnon E, Kostin S, Schonburg M, Elsasser A, Polyakova V, et al. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation 2003; 107:984-991.
19. Abbate A, Bussani R, Amin MS, Vetrovec GW, Baldi A. Acute myocardial infarction and heart failure: role of apoptosis. Int J Biochem Cell Biol 2006; 38:1834-1840; Epub 2006 May 12.
20. Carabello BA. Concentric versus eccentric remodelling. J Card Fail 2002; 8 (6 Suppl):S258-S263.
21. Adams JW, Sakata Y, Davis MG, Sah VP, Wang Y, Liggett SB, et al. Enhanced Galphaq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure. Proc Natl Acad Sci 1998; 18:10140-10145.
22. Yussman MG, Toyokawa T, Odley A, Lynch RA, Wu G, Colbert MC, et al. Mitochondrial death protein Nix is induced in cardiac hypertrophy and triggers apoptotic cardiomyopathy. Nat Med 2002; 8:725-730.
23. Hirota H, Chen J, Betz UA, Rajewsky K, Gu Y, Ross J Jr, et al. Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress. Cell 1999; 97:189-198.
24. Uozumi H, Hiroi Y, Zou Y, Takimoto E, Toko H, Niu P, et al. gp130 plays a critical role in pressure overload-induced cardiac hypertrophy. J Biol Chem 2001; 276:23115-23119.
25. Hikoso S, Yamaguchi O, Higuchi Y, Hirotani S, Takeda T, Kashiwase K, et al. Pressure overload induces cardiac dysfunction and dilatation in signal transducer and activator of transcription 6-deficient mice. Circulation 2004; 110:2631-2637.
26. Abbate A, Biondi-Zoccai GG, Bussani R, Dobrina A, Camilot D, Feroce F, et al. Increased myocardial apoptosis in patients with unfavorable left ventricular remodeling and early symptomatic postinfarction heart failure. J Am Coll Cardiol 2003; 41:753-760.
27. Sharov VG, Todor A, Suzuki G, Morita H, Tanhehco EJ, Sabbah HN. Hypoxia, angiotensin-II, and norepinephrine mediated apoptosis is stimulus specific in canine failed cardiomyocytes: a role for p38 MAPK, Fas-L and cyclin D1. Eur J Heart Fail 2003; 5:121-129.
28. Zhang S, Ren J, Zhang CE, Treskov I, Wag Y, Muslin AJ. Role of 14-3-3-mediated p38 mitogen-activated protein kinase inhibition in cardiac myocyte survival. Circ Res 2003; 93:1026-1028.
29. Lakò-Futò Z, Szokodi I, Sàrmàn B, Foldes G, Tokola H, Ilves M, et al. Evidence for a functional role of angiotensin II type 2 receptor in the cardiac hypertrophic process in vivo in the rat heart. Circulation 2003; 108:2414-2422.
30. Bruckschlegel G, Holmer SR, Jandeleit K, Grimm D, Muders F, Kromer EP, et al. Blockade of the renin-angiotensin system in cardiac pressure-overload hypertrophy in rats. Hypertension 1995; 25:250-259.
31. Holtz J. Role of ACE inhibition or AT1 blockade in the remodelling following myocardial infarction. Basic Res Cardiol 1998; 93 (Suppl 2):92-100.
32. Diez J, Panizo A, Hernandez M, Vega F, Sola I, Fortuno MA, et al. Cardiomyocyte apoptosis and cardiac angiotensin-converting enzyme in spontaneously hypertensive rats. Hypertension 1997; 30:1029-1034.
33. Li Z, Bing OH, Long X, Robinson KG, Lakatta EG. Increased cardiomyocyte apoptosis during the transition to heart failure in the spontaneously hypertensive rat. Am J Physiol 1997; 272 (5 Pt 2):H2313-H2319.
34. Kajstura J, Cigola E, Malhotra A, Li P, Cheng W, Meggs LG, et al. Angiotensin II induces apoptosis of adult ventricular myocytes in vitro. J Mol Cell Cardiol 1997; 29:859-870.
35. Goldenberg I, Grossman E, Jacobson KA, Shneyvays V, Shainberg A. Angiotensin II-induced apoptosis in rat cardiomyocyte culture: a possible role of AT1 and AT2 receptors. J Hypertens 2001; 19:1681-1689.
36. Abbate A, Scarpa S, Santini D, Palleiro J, Vasaturo F, Miller J, et al. Myocardial expression of survivin, an apoptosis inhibitor, in aging and heart failure. An experimental study in the spontaneously hypertensive rat. Int J Cardiol 2006; 111:371-376.
37. Westhuyzen J, Cochrane AD, Tesar PJ, Mau T, Cross DB, Frenneaux MP, et al. Effective of preoperative supplementation with α-tocopherol and ascorbic acid on myocardial injury in patients undergoing cardiac operations. J Thorac Cardiovasc Surg 1997; 113:942-948.
38. Okada K, Minamino T, Tsukamoto Y, Liao Y, Tsukamoto O, Takashima S, et al. Prolonged endoplasmic reticulum stress in hypertrophic and failing heart after aortic constriction - possible contribution of endoplasmic reticulum stress to cardiac myocyte apoptosis. Circulation 2004; 110:705-712.
39. Ding B, Abe J, Wei H, Huang Q, Walsh RA, Molina CA, et al. Functional role of phosphodiesterase 3 in cardiomyocyte apoptosis: implication in heart failure. Circulation 2005; 111:2469-2476.
40. Moorjani N, Ahmad M, Catarino P, Brittin R, Trabzuni D, Al-Mohanna F, et al. Activation of apoptotic caspase cascade during the transition to pressure overload-induced heart failure. J Am Coll Cardiol 2006; 48:1451-1458.
41. Yamamoto S, Sawada K, Shimomura H, Kawamura K, James TN. On the nature of cell death during remodelling of hypertrophied human myocardium. J Mol Cell Cardiol 2000; 32:161-175.
42. Gimelli A, Schneider-Eicke J, Neglia D, Sambuceti G, Giorgetti A, Bigalli G, et al. Homogeneously reduced versus regionally impaired myocardial blood flow in hypertensive patients; two different patterns of myocardial perfusion associated with degree of hypertrophy. J Am Coll Cardiol 1998; 31:366-373.
43. Rajappan K, Rimoldi OE, Dutka DP, Ariff B, Pennell DJ, Sheridan DJ, et al. Mechanisms of coronary microcirculatory dysfunction in patients with aortic stenosis and angiographically normal coronary arteries. Circulation 2002; 105:470-476.
44. Galiuto L, Lotrionte M, Crea F, Anselmi A, Biondi-ZoccaiGG, De Giorgio F, et al. Impaired coronary and myocardila flow in severe aortic stenosis is associated with increased apoptosis: a transthoracic Doppler and myocardial contrast echocardiography study. Heart 2006; 92:208-212.
45. Matturri L, Milei J, Grana DR, Lavezzi AM. Characterization of myocardial hypertrophy by DNA content, PCNA expression and apoptotic index. Int J Cardiol 2002; 82:33-39.
46. Dorn GW II. Adrenergic pathways and left ventricular remodelling. J Card Fail 2002; 8 (6 Suppl):S370-S373.
47. Gaudino M, Alessandrini F, Glieca F, Luciani N, Cellini C, Pragliola C, et al. Survival after aortic valve replacement for aortic stenosis: does left ventricular mass regression have a clinical correlate? Eur Heart J 2005; 26:51-57.
48. Teiger E, Than VD, Richard L, Wisnewsky C, Tea BS, Gaboury L, et al. Apoptosis in pressure overload-induced heart hypertrophy in the rat. J Clin Invest 1996; 97:2891-2897.
49. Kostin S, Pool L, Elsasser A, Hein S, Drexler HC, Arnon E, et al. Myocytes die by multiple mechanisms in failing human hearts. Circ Res 2003; 92:715-724.